How Much Upside Is Left in JNJ Stock?
While the market fixates on the STELARA patent cliff, the rest of the story is being missed. That…
Johnson & Johnson Is Becoming A Narrower Company Than You Bought
Management’s plain health care label has slipped out of the lead, and the business now on a separation…
The Real Engine Behind Johnson & Johnson Stock’s Next Climb
While many investors focus on a slowdown in one business segment, they may be overlooking the remarkable growth…